A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level

COVID‐19 afflicts patients with acute symptoms and longer term sequelae. One of the sequelae is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is often difficult to diagnose, having no established tests. In this article, we synthesize information from literature reviews on patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Jinushi, Ryuhei, Nishiguchi, Sho, Masuda, Sakue, Sasaki, Akiko, Koizumi, Kazuya, Ryozawa, Shomei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913186/
https://www.ncbi.nlm.nih.gov/pubmed/36789311
http://dx.doi.org/10.1002/ccr3.6930
_version_ 1784885363780616192
author Jinushi, Ryuhei
Nishiguchi, Sho
Masuda, Sakue
Sasaki, Akiko
Koizumi, Kazuya
Ryozawa, Shomei
author_facet Jinushi, Ryuhei
Nishiguchi, Sho
Masuda, Sakue
Sasaki, Akiko
Koizumi, Kazuya
Ryozawa, Shomei
author_sort Jinushi, Ryuhei
collection PubMed
description COVID‐19 afflicts patients with acute symptoms and longer term sequelae. One of the sequelae is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is often difficult to diagnose, having no established tests. In this article, we synthesize information from literature reviews on patients with ME/CSF that developed after recovery from COVID‐19.
format Online
Article
Text
id pubmed-9913186
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99131862023-02-13 A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level Jinushi, Ryuhei Nishiguchi, Sho Masuda, Sakue Sasaki, Akiko Koizumi, Kazuya Ryozawa, Shomei Clin Case Rep Case Report COVID‐19 afflicts patients with acute symptoms and longer term sequelae. One of the sequelae is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is often difficult to diagnose, having no established tests. In this article, we synthesize information from literature reviews on patients with ME/CSF that developed after recovery from COVID‐19. John Wiley and Sons Inc. 2023-02-10 /pmc/articles/PMC9913186/ /pubmed/36789311 http://dx.doi.org/10.1002/ccr3.6930 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Report
Jinushi, Ryuhei
Nishiguchi, Sho
Masuda, Sakue
Sasaki, Akiko
Koizumi, Kazuya
Ryozawa, Shomei
A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level
title A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level
title_full A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level
title_fullStr A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level
title_full_unstemmed A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level
title_short A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level
title_sort case of post‐covid‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913186/
https://www.ncbi.nlm.nih.gov/pubmed/36789311
http://dx.doi.org/10.1002/ccr3.6930
work_keys_str_mv AT jinushiryuhei acaseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel
AT nishiguchisho acaseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel
AT masudasakue acaseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel
AT sasakiakiko acaseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel
AT koizumikazuya acaseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel
AT ryozawashomei acaseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel
AT jinushiryuhei caseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel
AT nishiguchisho caseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel
AT masudasakue caseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel
AT sasakiakiko caseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel
AT koizumikazuya caseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel
AT ryozawashomei caseofpostcovid19myalgicencephalomyelitischronicfatiguesyndromecharacterizedbypostexertionalmalaiseandlowserumacylcarnitinelevel

Ejemplares similares